Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cirrhosis: A Questioned Risk Factor for Hepatocellular Carcinoma
Amanda Garrido, Nabil Djouder
Trends in cancer (2020) Vol. 7, Iss. 1, pp. 29-36
Closed Access | Times Cited: 98

Showing 51-75 of 98 citing articles:

Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma
Yue-Ling Peng, Lingxiao Wang, Mu-Ye Li, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0279744-e0279744
Open Access | Times Cited: 3
The impact of liver fibrosis on the progression of hepatocellular carcinoma via a hypoxia-immune-integrated prognostic model
Qianyuan Li, Junbo Zhang, Sheng Xiao, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111136-111136
Closed Access | Times Cited: 3
Mimics of hepatocellular carcinoma: a review and an approach to avoiding histopathological diagnostic missteps
Dauod Arif, Tetyana Mettler, Oyedele Adeyi
Human Pathology (2020) Vol. 112, pp. 116-127
Closed Access | Times Cited: 8
Pressure Loading Induces DNA Damage in Human Hepatocyte Line L02 Cells via the ERK1/2–Dicer Signaling Pathway
Yanping Tang, Yanan Fan, Qing Luo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5342-5342
Open Access | Times Cited: 5
Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis
Bao‐Wen Tian, Lun‐Jie Yan, Zi‐Niu Ding, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109519-109519
Closed Access | Times Cited: 5
miR-3651 Participates in the Growth Cycle of Hepatocellular Carcinoma Cells and Promotes the Malignant Metastasis via the PI3K/AKT/mTOR Signalling Pathway
Yawei Liu, Litian Hu, Qinqiang Liu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 4
Safety and efficacy of endoscopic retrograde cholangiopancreatography in previously treated liver cancer patients: a survival analysis
Hongyu Li, Jia Lijun, Wujun Du, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies
Pei‐Chin Lin, Wan‐Yi Hsu, Po‐Yi Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12654-12654
Open Access | Times Cited: 2
Liuweiwuling Tablet relieves the inflammatory transformation of hepatocellular carcinoma by inhibiting the PI3K/AKT/NF-κB signaling pathway
Yuanyuan Chen, Zheng Song, Xiaorong Hou, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117406-117406
Closed Access | Times Cited: 2
Noval ceRNA axis-mediated high expression of TOP2A correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma
Yang Wang, Xiaoqing Wang, Lili Li, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 12, pp. 3486-3502
Open Access | Times Cited: 2
Role of Transient Elastography (Fibroscan) in Early prediction of Hepatitis C Virus Related Hepatocellular Carcinoma
Mohammed N. Abou Hia Allah, Ashraf Omar Abdelaziz, Mohammed H. Al-Nadry, et al.
Al-Azhar International Medical Journal /Al-Azhar International Medical Journal (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 2
Usefulness of the estimation of physiologic ability and surgical stress (E-PASS) system for prediction of complication and prognosis in hepatocellular carcinoma patients after hepatectomy
Yili Dai, Guoqiao Chen, Yongle Chen, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 8, pp. 2700-2712
Open Access | Times Cited: 3
Biejia-Ruangan compound and incidence of hepatocellular carcinoma
Lei Luo, Xuebing Yao, Wenlong Yang
Journal of Hepatology (2022) Vol. 78, Iss. 4, pp. e141-e142
Closed Access | Times Cited: 3
Causes of death and nomogram for patients with oncologic hepato-biliary-pancreatic disorders: A large-cohort study
Jia Xu, Shu Huang, Qiong Yan, et al.
Medicine (2024) Vol. 103, Iss. 8, pp. e37187-e37187
Open Access
Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responses
Yizhou Wang, Peipei Shang, Chang Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation model
Tongqiang Li, Jiacheng Liu, Yingliang Wang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Postoperative SIRS after thermal ablation of HCC: Risk factors and short-term prognosis
Xiaorong Peng, Jibin Xing, Hao Zou, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25443-e25443
Open Access
Molecular Interaction Study between Gentamicin and the Cancer Protein Target (TP53) using in silico Tools
M Priyadharshini, D. Leelavathi, Tanzeem Azeeza S.
UTTAR PRADESH JOURNAL OF ZOOLOGY (2024) Vol. 45, Iss. 3, pp. 233-240
Open Access
The “Sweat Soaking Method”-processed Radix Wikstroemia indica Extracts Attenuate Liver Toxicity and its Effect on Cytochrome P450 Protein
Wenjing Wang, Guo Feng, Qin Xu, et al.
Pharmacognosy Magazine (2024) Vol. 20, Iss. 3, pp. 832-840
Open Access
The Combined Use of Dickkopf-1 and Soluble Axl Improves Hepatocellular Carcinoma Diagnostic Efficacy in Hepatitis C Patients
Ereny Samuell, Abdel-Aziz Abdel-Aziz, Ahmed Shehata, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 6, pp. 2185-2191
Open Access
The Comparative Metabolism of a Novel Hepatocellular Carcinoma Therapeutic Agent, 2,3-Diamino-N-(4-(benzo[d]thiazol-2-yl)phenyl)propanamide, in Human and Animal Hepatocytes
Young‐Heun Jung, Dong-Cheol Lee, Ye‐Min Kwon, et al.
Metabolites (2024) Vol. 14, Iss. 8, pp. 425-425
Open Access
The influence of peritumoral parenchyma on local tumor progression of hepatocellular carcinoma after thermal ablation
Wenzhen Ding, Mingsen Bi, Yongyan Gao, et al.
Research Square (Research Square) (2024)
Open Access
The influence of peritumoral parenchyma on local tumor progression of hepatocellular carcinoma after thermal ablation: a retrospective multicenter study
Wenzhen Ding, Mingsen Bi, Yongyan Gao, et al.
Abdominal Radiology (2024)
Open Access
Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals
Ke Shi, Ping Li, Qun Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Emerging Role of MicroRNA-Based Theranostics in Advanced Hepatocellular Carcinoma
Abdulhakim Umar Toro, Abdulaziz Umar Kurya, Sudheesh K. Shukla, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1

Scroll to top